Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: An animal model

Anticancer Research

Volumn 31, Issue 3, 2011, Pages 929-932

  Hou, Jack Cheng Tsung ^a   Landas, Steve ^b   Wang, Ching Y ^a   Shapiro, Oleg ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Bladder cancer; Intravesical chemotherapy; Mitomycin C

Indexed keywords

MITOMYCIN C; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; BLADDER MUCOSA; CANCER SURGERY; CHRONIC INFLAMMATION; CYSTECTOMY; CYSTITIS; CYSTOSTOMY; DISEASE DURATION; FEMALE; FIBROSIS; HISTOPATHOLOGY; INTERSTITIAL CYSTITIS; NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSURETHRAL BLADDER RESECTION; WOUND HEALING IMPAIRMENT;

ADMINISTRATION, INTRAVESICAL; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; MITOMYCIN; RATS; RATS, SPRAGUE-DAWLEY; URETHRA; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES; WOUND HEALING;

EID: 79956066214     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer Statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Carmack AJ and Soloway MS: The diagnosis and staging of bladder cancer from RBCs to TURs. Urology 67(3 suppl 1): 3-8, 2006.
3. Shapiro O, Jones K, Wang C, Landas S and Haas GP: Risk of post-operative intravesical mitomycin C instillation following transurethral bladder resection. Can J Urol 13: 3317-3320, 2006.
4. Sylvester RJ, Oosterlinck W and van der Meijden AP: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171: 2186-2190, 2004. (Pubitemid 38625431)
5. Rajala P, Kaasinen E, Raitanen M, Liukkonen T, Rintala E and Finn Bladder Group: Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a prospective randomized multicenter study-Finn Bladder III long-term results. J Urol 168: 981-985, 2002.
6. Solsona E, Iborra I, Ricos JV, Monros JL, Casanova J and Dumont R: Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up. J Urol 161: 1120-1123, 1999. (Pubitemid 29426099)
7. Tolley DA, Hargreave TB, Smith PH, Williams JL, Grigor KM, Parmar MK, Freedman LS and Uscinska BM: The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow-up. J Urol 155: 1233-1238, 1996.
8. Bouffioux C, Kurth KH, Bono A, Oosterlinck W, Kruger CB, De Pauw M and Sylvester R: Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group. J Urol 153: 934-941, 1995.
9. Cliff AM, Romaniuk CS and Parr NJ: Perivesical inflammation after early mitomycin C instillation. BJU Int 85: 556-557, 2000. (Pubitemid 30142641)
10. Nieuwenhuijzen JA, Bex A, Horenblas S, Nieuwenhuijzen JA, Bex A and Horenblas S: Unusual complication after immediate postoperative intravesical mitomycin C instillation. Eur Urol 43: 711-712, 2003. (Pubitemid 36648615)
11. Racioppi M, Porreca A, Foschi N, Delicato G, Destito A and D'Addessi A: Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C. Urol Int 75: 373-375, 2005.
12. He M, Sheldon PJ and Sherman DH: Characterization of a quinone reductase activity for the mitomycin C binding protein (MRD): Functional switching from a drug-activating enzyme to a drug-binding protein. Proc Natl Acad Sci USA 98: 926-931, 2001. (Pubitemid 32121164)
13. Joseph P, Xu Y and Jaiswal AK: Non-enzymatic and enzymatic activation of mitomycin C: identification of a unique cytosolic activity. Int J Cancer 65: 263-271, 1996. (Pubitemid 26051689)